MedStorm Innovation
www.med-storm.comMedStorm offers a unique solution to improve the quality of pain management and daily workload in the wards. Pain is treated as the fifth vital sign, emphasizing the importance of high-quality pain management. The use of MedStorm's PainMonitor can, among others, tailor the need for analgesia, reduce side effects from over- and under sedation, as well as reducing the length of stay and therefore also costs for the hospitals. Our real-time PainMonitor device is based on skin conductance changes during anaesthesia, intensive care, postoperatively and in preterm infants. Additionally, the device has indices for assessing awakening, withdrawal symptoms, and the effect of regional nerve-block within seconds. Our technology is based on 20 years of medical research, and there are more than 70 supportive validation studies and 3 theses, see https://med-storm.com/clinical/references/. All studies show that the index increases during pain and nociceptive stimuli, and may predict painful events more sensitively and specifically than other available tools in all age groups. Moreover, the index decreases when analgesia is given. The index reacts within seconds, has low variation between and within individuals, and has higher accuracy to assess pain responses as compared to current methods. For more information about our technology, visit https://med-storm.com/ or contact us at support@med-storm.com.
Read moreMedStorm offers a unique solution to improve the quality of pain management and daily workload in the wards. Pain is treated as the fifth vital sign, emphasizing the importance of high-quality pain management. The use of MedStorm's PainMonitor can, among others, tailor the need for analgesia, reduce side effects from over- and under sedation, as well as reducing the length of stay and therefore also costs for the hospitals. Our real-time PainMonitor device is based on skin conductance changes during anaesthesia, intensive care, postoperatively and in preterm infants. Additionally, the device has indices for assessing awakening, withdrawal symptoms, and the effect of regional nerve-block within seconds. Our technology is based on 20 years of medical research, and there are more than 70 supportive validation studies and 3 theses, see https://med-storm.com/clinical/references/. All studies show that the index increases during pain and nociceptive stimuli, and may predict painful events more sensitively and specifically than other available tools in all age groups. Moreover, the index decreases when analgesia is given. The index reacts within seconds, has low variation between and within individuals, and has higher accuracy to assess pain responses as compared to current methods. For more information about our technology, visit https://med-storm.com/ or contact us at support@med-storm.com.
Read moreCountry
City (Headquarters)
Oslo
Industry
Employees
11-50
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Technology Officer
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Member of the Board of Advisors
Email ****** @****.comPhone (***) ****-****Clinical Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(11)